Leonardo Jaimes, MD

All articles by Leonardo Jaimes, MD

• Donor characteristics may affect quality of FNAIT transfusions

  A recent study showed donor characteristics can affect the quantity of platelets obtained for FNAIT platelet transfusions.

• Potential therapeutic alternative for FNAIT shows early promise

  Researchers have successfully synthesized an antibody against the CD36 platelet antigen, which has potential therapeutic implications for FNAIT.

• Study: No significant difference between FNAIT diagnostic tests

  A recent study found no significant differences in accuracy between methods for detecting detecting anti-HPA antibodies responsible for FNAIT.

• FcRn inhibitors as a potential treatment for FNAIT

  Neonatal fragment crystallizable receptor (FcRn) inhibitors could significantly decrease complications associated with FNAIT, recent studies show.

• Drug to prevent FNAIT shows promise in early-stage trial

  Results from the phase 1 clinical trial of RLYB212, an experimental therapy intended for FNAIT prevention, were recently published.

• UNITY fetal antigen test to be used in phase 3 nipocalimab trial

  BillionToOne will allow its UNITY fetal antigen test to be used to test patients in the phase 3 trial evaluating the safety and efficacy of nipocalimab.